Source: FDA to follow guidance for COVID-19 vaccine

Source: FDA to follow guidance for COVID-19 vaccine

The FDA plans to follow guidance issued in June that calls for any COVID-19 vaccine candidate to be at least 50% effective to be considered for approval, regardless of whether it is submitted via emergency or traditional channels, according to an agency official with knowledge of the matter. The FDA has been striving to send a message that vaccine review decisions will not be influenced by politics.

Full Story: Bloomberg (tiered subscription model) (9/8)